In vitro activity of terbinafine against clinical isolates of dermatophytes

Medical Mycology

Volumn 36, Issue 4, 1998, Pages 235-237

  Arzeni, D ^a   Barchiesi, F ^a   Compagnucci, P ^a   Cellini, A ^a   Simonetti, O ^a   Offidani, A M ^a   Scalise, G ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Dermatophytes; In vitro susceptibility testing; Terbinafine

Indexed keywords

TERBINAFINE;

ANTIFUNGAL ACTIVITY; ARTICLE; DERMATOPHYTE; DOSE RESPONSE; FUNGICIDAL ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; STANDARD;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; SPECIES SPECIFICITY;

ARTHRODERMATACEAE; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031881121     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-280X.1998.00144.x     Document Type: Article

References (10)

1. Rashid A, Edward M, Richardson MD. Activity of terbinafine on Trichophyton mentagrophytes in a human living skin equivalent model. J Med VetMycol 1995; 95: 229-233.
2. Balfour JA, Faulds D. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 1992; 43: 259-284.
3. Roberts MM. Developments in the management of superficial fungal infections. J Antimicrob Chemother 1991; 28: 47-57.
4. National Committee for Clinical Laboratory Standard. Reference method for broth dilution antifungal susceptibility testing of yeasts; tentative standard. NCCLS document M27-T. Villanova PA, 1995.
5. Espinel-Ingroff A, Dawson K, Pfaller M, et al. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrob Agents Chemother 1995; 95: 314-319.
6. Petranyi G, Meingassner JG, Mieth H. Antifungal activity of the allylamine derivate terbinafine in vitro. Antimicrob Agents Chemother 1987; 31: 1365-1368.
7. Kovarik JM, Mueller EA, Zehender H, Denouel J, Caplain H, Millerioux L. Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites. Antimicrob Agents Chemother 1995; 95: 2738-2741.
8. Korting HC, Ollert M, Abeck D and the German Collaborative Dermatophyte Drug Susceptibility Study Group. Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. Antimicrob Agents Chemother 1995; 39: 1206-1208.
9. Aly R, Berger T. Common superficial fungal infections in patient with AIDS. Clin Infect Dis 1996; 22 (Suppl. 2): 128-132.
10. Ray MC. Gately, LE. Dermatologic manifestations of HIV infection in AIDS. Infect Dis Clin North Am 1994; 94: 583-605.